Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Inhibikase Therapeutics (NASDAQ:IKT) Earnings: Is the $159 Million Cash Pile Enough to Reach Phase 3 Data?

Inhibikase Therapeutics (NASDAQ:IKT) had not published third-quarter results as of Wednesday, October 28, and its filings show no report on Tuesday, October 27. The latest release, dated August 11, covers the quarter ended June 30 and reported a net loss of $19.6 million, or …

Vinay Lochav | 28 October 2026

Innio (NASDAQ:INIO) Earnings: Is Record Data Center Demand Behind the Raised 2026 Outlook?

Innio (NASDAQ:INIO) reported third-quarter results before the open on Tuesday, October 27, with revenue of $1,167.9 million, up 57%, and diluted EPS of $0.15 against $0.05. Management raised 2026 revenue guidance to $3.9 billion to $4.0 billion from $3.8 billion to $3.9 billion, and …

Vinay Lochav | 28 October 2026

InsuraGuest Technologies (OTC:ISGIF) Earnings: Is Margin Growth at a Tiny Insurtech the Detail Investors Are Missing Before the Fiscal Report?

InsuraGuest Technologies (OTC:ISGIF) has a June 30 fiscal year end and has not issued results for fiscal 2026 as of Wednesday, October 28. No report appeared on Tuesday, October 27, and the next earnings date is shown as Thursday, October 29. No analyst estimate …

Vinay Lochav | 28 October 2026

Intapp (NASDAQ:INTA) Earnings: Is 29% Subscription Growth Enough to Offset a Sliding License Line?

Intapp (NASDAQ:INTA) reported fiscal first-quarter 2027 results for the period ended September 30 after the close on Tuesday, October 27. Total revenue was $161.3 million, up 16% from $139.0 million, and non-GAAP diluted EPS was $0.44 versus $0.24. The screen estimate was $0.40.

Vinay Lochav | 28 October 2026

2027 Outlooks and Fiscal 2027 Guides: Did You Miss Johnson Controls (NYSE:JCI), SoFi Technologies (NASDAQ:SOFI), CenterPoint Energy (NYSE:CNP) and More?

Six reporters on Tuesday, October 27, gave their first forward numbers beyond the current year. Johnson Controls (NYSE:JCI) guided fiscal 2027 adjusted EPS to $6.15 to $6.30 after orders rose 44% organically. SoFi Technologies (NASDAQ:SOFI) set 2027 adjusted net revenue at about $6.4 billion. …

Vinay Lochav | 28 October 2026

Did InvenTrust Properties (NYSE:IVT) Raise Its 2026 Core FFO Outlook on Leasing Spreads Investors May Be Missing?

InvenTrust Properties (NYSE:IVT) reported third-quarter results on Tuesday, October 27, with Core FFO of $0.50 per diluted share, up from $0.47 a year earlier. Nareit FFO was $0.53, compared with $0.49, and net income was $0.25 per share, compared with $0.08. Management raised the …

Vinay Lochav | 28 October 2026

Invesco (NYSE:IVZ) Earnings: Did a 40.7% Margin Offset an Adjusted EPS Miss and Slower Inflows?

Invesco (NYSE:IVZ) reported third-quarter adjusted diluted EPS of $0.72 on Tuesday, October 27, up from $0.61 a year earlier and $0.71 in the second quarter. As screened, the estimate was $0.74, a surprise of negative 2.55%. GAAP diluted EPS was $0.65, versus $0.66 a …

Vinay Lochav | 28 October 2026

IQVIA (NYSE:IQV) Earnings: Why Did a $2.1 Billion Backlog Cut Come With a Raised 2026 Outlook?

IQVIA Holdings (NYSE:IQV) reported third-quarter results on Tuesday, October 27, with adjusted diluted EPS of $3.34, up 11.3% from $3.00, and GAAP diluted EPS of $2.10 versus $1.93. The screened estimate was $3.28, a surprise of 1.96% as screened. Revenue rose 8.0% to $4,428 …

Vinay Lochav | 28 October 2026

Did Itron (NASDAQ:ITRI) Earnings Beat Hide a 0.80 Book-to-Bill? What Investors May Be Missing

Itron (NASDAQ:ITRI) reported third-quarter results on Tuesday, October 27, with non-GAAP diluted EPS of $1.94, up 26%, against an estimate of $1.56. GAAP diluted EPS was $1.61, up 14%. Revenue rose 3% to $599.3 million, also 3% in constant currency, above a market estimate …

Vinay Lochav | 28 October 2026

Johnson Controls (NYSE:JCI) Earnings: Why Did Orders Surge 44% and What Does the Fiscal 2027 Guide Say?

Johnson Controls International (NYSE:JCI) reported fiscal fourth-quarter results on Tuesday, October 27, for the quarter ended September 30. Sales were $7.113 billion, up 10%, and organic sales grew 12%. Adjusted EPS was $1.66 against $1.26 a year earlier, a gain of about 32% by …

Vinay Lochav | 28 October 2026
Support

Hi! How can we help you today?

Loading…